Surviving Fournier's gangrene: Multivariable analysis and a novel scoring system to predict length of stay
Introduction
Fournier's gangrene is a rapidly progressive necrotizing fasciitis of the genital, perineal and perianal regions caused by bacterial infection. Within the last thirty years, the natural history of Fournier's gangrene has changed, transitioning from a disease with mortality reported as high as 50% to a disease with a much lower mortality rate of approximately 10% or less.1, 2, 3, 4 These advances are likely due to more aggressive debridement and intervention with IV antibiotics, as well as advances in critical care.5 Subsequently, several recent studies have reported improved survival in Fournier's gangrene.1, 2, 4, 6, 7, 8
In the past, scoring systems for Fournier's gangrene were designed to predict mortality. However, patients with Fournier's gangrene are increasingly surviving this disease due to improved intervention, and subsequent survivors require lengthy hospital stays including pelvic debridement and the need for reconstruction.1, 9 Therefore, the focus of Fournier's management is shifting from preventing mortality to reducing morbidity, resource utilization and length of hospital stay, and as such, updated scoring systems are needed to predict these parameters.1, 10, 11 To date, there is no scoring system in use for predicting length of stay in patients with Fournier's gangrene.
It is the aim of this study to identify patient factors associated with hospital length of stay in patients with Fournier's gangrene, and to use these factors to create a novel scoring system that can accurately predict length of stay at the time of admission. Through the use of such a scoring system, patients requiring more extensive hospital management can be identified. Consequently, resources will be better allocated to patients based on a systematic assessment of healthcare needs, with the goal of improving patient outcomes and reducing hospital costs.
Section snippets
Study population
This was a collaborative, multi-departmental retrospective study at LAC+USC Medical Center, the largest public hospital serving indigent patients in Los Angeles County. Patients were identified through a retrospective chart review using an IRB-approved protocol. Inclusion criteria were a diagnosis of true Fournier's gangrene, positive bacterial cultures, and having undergone surgical debridement during hospital stay. Patients with superficial abscesses were excluded. There were 54 patients
Patient characteristics
Patient ages ranged between 24 and 76, with a mean age of 49.3 (SD 10.9) (Table 1). Average patient BMI was 28.6 (SD 7.6), and ranged from 16 to 50. All patients were male in this study, 67% were Hispanic and 65% had diabetes. Many were smokers (43%) and alcoholics (26%). All patients had an initial wound culture positive for bacterial growth and 77% had polymicrobial infections identified on culture. The median day of initial debridement was day 0, meaning most patients were taken to the OR on
Discussion
Management of Fournier's gangrene has fundamentally changed in the past thirty years.14 Critical care has improved, and surgeons have increased rates of intervention with aggressive treatment of this disease. Consequently, many more are surviving this previously deadly infection. Survivors face severe deformity, and the impetus is upon surgeons to improve survival and long-term outcomes.
In this study, patient characteristics were consistent with other past articles, including the involvement of
Conclusions
The CUPI scoring system helps to predict length of stay in patients with Fournier's gangrene, and may help direct increasing care to at-risk patients. Multi-disciplinary care, aggressive nutrition and operative intervention all contribute to successful treatment for Fournier's gangrene with lower mortality rates, but also result in significant hospital stays and a greater need for reconstruction. Beyond predicting length-of-stay at admission, the CUPI score may provide a quantitative scoring
Conflict of interest
None of the authors have relevant financial disclosures. No funding was received for the conduct of this research.
References (21)
- et al.
Contemporary trends in the inpatient management of Fournier's Gangrene: predictors of length of stay and mortality based on population-based sample
Urology
(2017) - et al.
Fournier's Gangrene: population based epidemiology and outcomes
J Urol
(2009) - et al.
Fournier's gangrene: three years of experience with 20 patients and validity of the Fournier's Gangrene Severity Index Score
Eur Urol
(2006) - et al.
Prognostic factors in Fournier gangrene
Asian J Surg
(2012) - et al.
Serum alkaline phosphatase and serum zinc levels in the diagnosis and exclusion of zinc deficiency in man
Am J Clin Nutr
(1985) - et al.
Predictive factors for mortality in Fournier' gangrene: a series of 59 cases
Cir Esp
(2015) - et al.
Validation of the Fournier's gangrene severity index in a large contemporary series
J Urol
(2008) - et al.
Fournier's gangrene: overview of prognostic factors and definition of new prognostic parameter
Urology
(2010) - et al.
New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients
Infection
(2009) - et al.
Fournier's gangrene: exists and it is still lethal
Int Urol Nephrol
(2006)
Cited by (0)
- 1
These authors contributed equally to this manuscript.